Skip to main content
OpenTrials

Clinical trial condition

Papillomavirus Vaccines

Explore clinical trials studying Papillomavirus Vaccines. Study availability and eligibility vary by location and protocol.

20 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Papillomavirus Vaccines trial results

Completed

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.

NCT00877877

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations
  • GSK Investigational Site Bogotá, Colombia
  • GSK Investigational Site Deggingen, Baden-Wurttemberg, Germany
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
View all 26 locations
View Trial Details
Completed

Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older

NCT00294047

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations
  • GSK Investigational Site Fountain Valley, California, United States
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Golden, Colorado, United States
  • GSK Investigational Site Coral Gables, Florida, United States
View all 75 locations
View Trial Details
Completed

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

NCT00423046

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Vista, California, United States
View all 40 locations
View Trial Details
Completed

Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine

NCT00359619

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +12 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Golden, Colorado, United States
  • GSK Investigational Site Salt Lake City, Utah, United States
  • GSK Investigational Site Salt Lake City, Utah, United States
View Trial Details
Completed

Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.

NCT00250276

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +12 more
Locations
  • GSK Investigational Site Hvidovre, Denmark
  • GSK Investigational Site Kaunas, Lithuania
  • GSK Investigational Site Klaipėda, Lithuania
  • GSK Investigational Site Vilnius, Lithuania
View Trial Details
Completed

AFIX to Improve HPV Vaccination

NCT02370459

Conditions
Adolescent Health Services, Papillomavirus Vaccines
Locations
  • Illinois Department of Public Health Springfield, Illinois, United States
  • Michigan Department of Community Health Lansing, Michigan, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Washington State Department of Health Olympia, Washington, United States
View Trial Details
Active, Not Recruiting

Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors

NCT04469569

Conditions
Papillomavirus Vaccines
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Emory University Atlanta, Georgia, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Wake Forest University Health Sciences Winston-Salem, North Carolina, United States
View Trial Details

Related conditions